INFLIXIMAB-DYYB

19232 reported adverse events

Drug classes: Tumor Necrosis Factor Blocker [EPC]

These side effects are most commonly reported by patients taking INFLIXIMAB-DYYB:

# Side effect Count
0 OFF LABEL USE 11299
1 CONDITION AGGRAVATED 7326
2 INTENTIONAL PRODUCT USE ISSUE 6083
3 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4777
4 ARTHRALGIA 3352
5 DRUG INEFFECTIVE 2629
6 WEIGHT INCREASED 2521
7 FATIGUE 2333
8 MALAISE 2270
9 WEIGHT DECREASED 2249
See all common reactions for INFLIXIMAB-DYYB

INFLIXIMAB-DYYB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FAECAL CALPROTECTIN INCREASED 508 0.2375
1 EAR INFECTION BACTERIAL 44 0.2095
2 DRUG LEVEL BELOW THERAPEUTIC 912 0.2056
3 SINUSITIS BACTERIAL 161 0.1914
4 TREATMENT DELAYED 105 0.1667
5 ANAL FISSURE 646 0.1645
6 DRUG LEVEL ABOVE THERAPEUTIC 502 0.1446
7 WHITE COAT HYPERTENSION 42 0.1228
8 FAECAL CALPROTECTIN ABNORMAL 26 0.1187
9 BRONCHITIS BACTERIAL 71 0.1132
See all enriched reactions for INFLIXIMAB-DYYB